Cargando…
Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer
Hypoxia promotes neovascularization, increased tumor growth, and therapeutic resistance. The transcription factor, hypoxia-inducible factor 1α (HIF-1α), has been reported as the master driver of adaptation to hypoxia. We previously identified the sphingosine kinase 1/sphingosine 1-phosphate (SphK1/S...
Autores principales: | Ader, Isabelle, Gstalder, Cécile, Bouquerel, Pierre, Golzio, Muriel, Andrieu, Guillaume, Zalvidea, Santiago, Richard, Sylvain, Sabbadini, Roger A., Malavaud, Bernard, Cuvillier, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537051/ https://www.ncbi.nlm.nih.gov/pubmed/25915662 |
Ejemplares similares
-
Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer
por: Bouquerel, P, et al.
Publicado: (2016) -
Metformin targets the GTPase Rac1 to inhibit prostate cancer cell migration
por: Dirat, Béatrice, et al.
Publicado: (2014) -
Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival
por: Dayon, Audrey, et al.
Publicado: (2009) -
Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate?
por: Lukovic, Jelena, et al.
Publicado: (2019) -
Tracheal remodelling in response to hypoxia
por: Centanin, Lazaro, et al.
Publicado: (2010)